A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans by Li, Yang et al.
  
 University of Groningen
A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans
Li, Yang; Oosting, Marije; Smeekens, Sanne P.; Jaeger, Martin; Aguirre-Gamboa, Raul; Le,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Li, Y., Oosting, M., Smeekens, S. P., Jaeger, M., Aguirre-Gamboa, R., Le, K. T. T., ... Netea, M. G. (2016).
A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans. Cell, 167(4),
1099-1110. https://doi.org/10.1016/j.cell.2016.10.017
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
ResourceA Functional Genomics Approach
to Understand Variation
in Cytokine Production in Humans
Yang Li,1,8,9,* Marije Oosting,2,8 Sanne P. Smeekens,2,8 Martin Jaeger,2,8 Raul Aguirre-Gamboa,1 Kieu T.T. Le,1
Patrick Deelen,1,3 Isis Rican˜o-Ponce,1 Teske Schoffelen,2 Anne F.M. Jansen,2 Morris A. Swertz,1,3 Sebo Withoff,1
Esther van de Vosse,4 Marcel van Deuren,2 Frank van de Veerdonk,2 Alexandra Zhernakova,1 Jos W.M. van der Meer,2
Ramnik J. Xavier,5,6 Lude Franke,1 Leo A.B. Joosten,2,* Cisca Wijmenga,1,7,* Vinod Kumar,1,* and Mihai G. Netea2,*
1Department of Genetics, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, the Netherlands
2Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 HP Nijmegen,
the Netherlands
3Genomics Coordination Center, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, the Netherlands
4Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands
5Center for Computational and Integrative Biology and Gastrointestinal Unit, Massachusetts General Hospital, Harvard School of Medicine,
Boston, MA 02114, USA
6Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA
7Department of Immunology, University of Oslo, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway
8Co-first author
9Lead Contact
*Correspondence: y.li01@umcg.nl (Y.L.), leo.joosten@radboudumc.nl (L.A.B.J.), c.wijmenga@umcg.nl (C.W.), v.kumar@umcg.nl (V.K.),
mihai.netea@radboudumc.nl (M.G.N.)
http://dx.doi.org/10.1016/j.cell.2016.10.017SUMMARY
As part of the Human Functional Genomics Project,
which aims to understand the factors that determine
the variability of immune responses, we investigated
genetic variants affecting cytokine production in
response to ex vivo stimulation in two independent
cohorts of 500 and 200 healthy individuals. We
demonstrate a strong impact of genetic heritability
on cytokine production capacity after challenge
with bacterial, fungal, viral, and non-microbial stimuli.
In addition to 17 novel genome-wide significant cyto-
kine QTLs (cQTLs), our study provides a comprehen-
sive picture of the genetic variants that influence six
different cytokines in whole blood, blood mononu-
clear cells, and macrophages. Important biological
pathways that contain cytokine QTLs map to pattern
recognition receptors (TLR1-6-10 cluster), cytokine
and complement inhibitors, and the kallikrein system.
The cytokine QTLs show enrichment for monocyte-
specific enhancers, are more often located in regions
under positive selection, and are significantly en-
riched among SNPs associated with infections and
immune-mediated diseases.
INTRODUCTION
The Human Functional Genomics Project (HFGP) is an initiative
that aims to identify the factors responsible for the variability
of immune responses in health and disease (http://www.humanfunctionalgenomics.org). Within the HFGP, the 500-Hu-
man Functional Genomics (500FG) cohort focuses on gaining a
broader understanding of the variability in human cytokine re-
sponses. In a first study reported in this issue of Cell, we investi-
gated the role of environmental and non-genetic host factors for
cytokine responses (ter Horst et al., 2016). In the present study,
we investigate the role of genetic variation for individuals human
cytokine responses,while a third complementary study assessed
the impact of microbiome factors (Schirmer et al., 2016).
Many targeted candidate gene studies have demonstrated the
impact of specific genetic variants on immune responses, while
a recent study that assessed the genetics of lipopolysaccharide
(LPS)-induced cytokine responses by dendritic cells identified
several candidate genes (Lee et al., 2014). Furthermore,
genome-wide genetic studies have found genetic variants that
impact transcript abundance for immune genes (so-called
eQTLs [expression quantitative trait loci]) (Kumar et al., 2014a;
Fairfax et al., 2014; Lee et al., 2014), while genome-wide associ-
ation studies (GWASs) have identified hundreds of genetic vari-
ants predisposing to the susceptibility to immune-mediated
diseases and/or their severity (Welter et al., 2014). However,
there have been no comprehensive genome-wide association
studies to investigate variation in cytokine production in humans
so far. As a proof of concept, we assessed the genetics of three
monocyte-derived cytokines (tumor necrosis factor a [TNF-a],
interleukin [IL]-1b, and IL-6) after stimulation with a fewmicrobial
stimuli: we identified four genome-wide loci that influence
cytokine release (Li et al., 2016). This clearly demonstrated the
importance of genetic variation for cytokine production in hu-
mans, and we decided to pursue a more comprehensive
approach to reveal the most important genetic factors that influ-
ence cytokine responses.Cell 167, 1099–1110, November 3, 2016 ª 2016 Elsevier Inc. 1099
Figure 1. Study Overview
We collected blood samples from 500 healthy individuals in the 500FG cohort and isolated their DNA. This was hybridized on the HumanCoreExome SNP Chip to
provide genotype information on approximately 8 million SNPs. The blood was also used to perform a series of stimulation experiments with major human
pathogens and to profile the cytokines released in the serum (see STAR Methods). See also Figures S1 and S2.Here, we describe the stimulation of three different cellular
systems (whole blood, peripheral blood mononuclear cells
[PBMCs], and macrophages) with a broad panel of bacterial,
fungal, viral, and non-microbial stimuli to induce cytokine pro-
duction, which was analyzed with approximately 8.0 million ge-
netic variants (SNPs). The discovery was performed in the
500FG cohort, and validation was performed in the 200FG
cohort.Wewere able to validate 17 newgenome-wide significant
loci that represent cytokine QTLs (cQTLs), and we describe new
pathways for the modulation of cytokine responses in humans.
RESULTS
Overview of Cytokine Response Architecture
We assessed cytokine production capacity in the 500FG discov-
ery cohort in three cellular systems: whole-blood stimulations,
PBMC stimulations, and stimulation of monocyte-derived mac-
rophages. We used a comprehensive range of seven bacterial,
three fungal, one viral, four Toll-like receptor (TLR) ligands, and1100 Cell 167, 1099–1110, November 3, 2016two non-microbial metabolic stimuli to assess three monocyte-
derived and three lymphocyte-derived cytokines (see Figure 1
for overview).
Significant increases in the levels of all cytokines were
observed in all stimulation systems compared to steady-state
levels (see also the related paper by Schirmer et al., 2016, for
the main bacterial and fungal stimuli, as well as Figure S1 for a
full description of all stimuli). Cytokines IL-6 and TNF-a from
whole blood and PBMCs showed higher inter-individual variation
than production by macrophages (Figure S2), suggesting that
the in vitro differentiation of macrophages is a process that partly
overrides individual variation. In general, IL-6 showed a much
stronger inter-individual variation than any other cytokines
(p < 0.001), suggesting a much stronger impact of cell types
and/or genetic variation on IL-6 production than other cytokines.
These results were consistent with those we obtained from the
200FG cohort (data not shown).
Unsupervised clustering of the cytokine responses showed a
clear distinction between stimulations with bacteria, fungi, or
Figure 2. The Cytokine Responses Are Organized around the Physiological Response toward Specific Pathogens
(A) The results from unsupervised hierarchical clustering of the cytokine responses in PBMCs induced by various pathogens and microbial ligands are shown.
Clustering was performed using Spearman’s correlation as the measure of similarity. Red indicates a strong positive correlation, whereas blue indicates a strong
negative correlation. Cluster 1 depicts the positive correlation between monocyte-induced cytokines (IL-6, IL-1b, and TNF-a) on stimulation of PBMCs for 24 hr.
Cluster 2 depicts the positive correlation among cytokines derived from T-helper cells (IL-17, IL-22, and IFN-g) on stimulation of PBMCs for 7 days. Cluster 3
depicts the strong correlation between influenza- and Cryptococcus-induced cytokines for both T cell- and monocyte-derived cytokines.
(B) The results from unsupervised hierarchical clustering of the cytokine responses in blood were compared with responses in PBMCs. The stimulation-cytokine
pairs that were available for both cell systems were chosen to perform unsupervised hierarchical clustering. Four different clusters indicate the pathogen-specific
clustering of cytokines. WB, whole blood.viruses (Figure 2A). Correlations between the productions of
various cytokines were foundmainly for stimulation with a certain
microbe rather than between cytokine productions induced by
different microbes, which suggests that immune responses are
organized to respond to a specific pathogen rather than through
a specific immune pathway. The clustering also revealed a poor
correlation between monocyte-derived- and T-helper-derived
cytokine responses (Figure 2A). This is surprising, as the differen-
tiation of naive T cells into Th1- or Th17-effector lymphocytes
is controlled by monocyte-derived cytokines. However, this
conclusion is also supported by our clustering analyses of
whole-blood stimulations (Figure 2B). An exception to these pat-
terns was the fungalCryptococcus-induced cytokine responses,
in which the distinction between monocyte-derived- and T cell-
derived cytokines was weak. In addition, the Cryptococcus-
induced cytokines were more similar to cytokine responses
induced by influenza virus than to other fungi (Figure 2A).
To assesswhether cell-based factors are the only factor deter-
mining variation in cytokine responses, or whether plasma-
derived factors can qualitatively modulate the responses, we
correlated specific responses in purified PBMCs versus whole-
blood stimulations (Figure 2B). Unsupervised clustering demon-
strated stronger correlations of responses in the two stimulationsystems, but we also found positive correlations between them
(Figure 2B). These findings suggest that, although intrinsic fac-
tors in the mononuclear cells mainly determine the cytokine
response, additional variation in cytokine production may also
be induced by other whole-blood components, such as neutro-
phils or plasma factors.
Contribution of Genetic Variation to How Cytokines
Respond to Pathogens
We observed that cytokines show higher inter-individual varia-
tion upon stimulation (Figure S2). Since a difference in cell-count
proportions can be an important factor influencing the amount
of cytokines produced, we tested whether cell-count differ-
ences determine inter-individual variation in cytokine levels.
For this, we obtained immune-cell-count data measured by
fluorescence-activated cell sorting (FACS) for total lymphocytes,
T cells, B cells, monocytes, and natural killer (NK) cells
from all 500FG individuals (Aguirre-Gamboa et al., 2016). We
observed weak correlations between cell counts and cytokine
levels (Figure S3A), suggesting aminor effect of cell-count differ-
ences on cytokine production capacity. We then estimated the
proportion of cytokine variance explained by genome-wide
SNPs for all cytokine measurements before and after correctingCell 167, 1099–1110, November 3, 2016 1101
Figure 3. Proportion of the Estimated Cytokine Variance Explained by Genetic Factors
A summary of all the estimates of cytokine variance explained by genome-wide SNP data after age, gender, and cell-count correction is shown. The esti-
mates <25% are shown in gray, and the estimates >50% are shown in black.
See also Figures S6 and S7 and Table S1.for age, gender, and cell counts (Figure 3; Figure S3B; Table S1)
using the GREML method (Yang et al., 2010).
In total, for around 70% of all the cytokine responses in
PBMCs, the genetic influence was considerably larger than pre-
viously reported (>25% of explained variance) (Brodin et al.,
2015). We found similar results when we estimated heritability
without correcting age, gender, and cell counts (Table S1). In
general, we found a higher explained variance for monocyte-
derived cytokines from genetic factors (>50% of explained
variance especially for IL-6 and IL1-b) than for T cell-derived cy-
tokines (Figure 3). Finding the strongest inter-individual variation
in IL-6 levels upon stimulation, in addition to the highest heritabil-
ity for IL-6 levels, indicates that theremay bemany genome-wide
significant QTLs for IL-6 in the context of infectious pressure. In
T cell-derived cytokines, we found a higher explained variance
for IL-17 from genetic factors. Although it may be expected
that the cytokine production capacity is affected by genetic fac-
tors, we observed that the estimated explained variance due to
genetic factors differed for the stimulation by the various micro-
organisms and for the individual cytokines studied. This finding
indicates there are genetic variations that may be strongly regu-
lating the cytokine production in response to certain pathogens.
Identifying Genome-wide Genetic Variations Affecting
Cytokine Production in Response to Pathogens
To identify the most significant genetic loci that determine cyto-
kine levels upon stimulation, we mapped cQTLs using genome-
wide SNP genotypes. After correcting for age, gender, and cell
counts, we identified 18 genome-wide (p < 5 3 108) significant
lead SNPs in 17 independent loci (Figures 4A and 4B). These1102 Cell 167, 1099–1110, November 3, 2016include seven independent QTLs for IL-6, three independent
QTLs for IL-1b, and three independent QTL for TNF-a levels
(Table 1). Of the 17 loci, all but one were identified for cytokines
measured after PBMC stimulations, while one locus on chromo-
some 19 came from the whole-blood stimulation system
(Table 1). We identified cQTLs for both monocyte- and T cell-
derived cytokines upon bacterial and fungal stimulations,
whereas stimulation with purified TLR ligands only yielded
cQTLs for monocyte-derived cytokines (Figure S3B). The validity
of the 17 loci was further corroborated for the 12 cytokine-micro-
bial stimulations that were performed in the 200FG cohort. Of the
cQTLs, 9/12 (75%) were replicated (p < 0.05), and, in all cases,
the effects were in the same direction (Table S2). We could not
replicate five of the cQTLs, as these stimulus-cytokine measure-
ments were not tested in the 200FG cohort. No genome-wide
significant cQTLs were identified for themacrophage production
of cytokines, which agrees with the conclusion that the process
of in vitro differentiation erases many of the differences between
individuals. This conclusion has important consequences, as it
suggests that in-vitro-differentiated cell systems (such as mono-
cyte-derived macrophages or dendritic cells) may not be suit-
able for studying the genetics of cytokine responses.
Prioritizing cQTL-Affected Genes Indicates Those
Involved inMicrobial Sensing and ProcessingMolecules
as Putative Causal Genes
We used three approaches to identify the causal genes at the 17
significant cQTL loci. First, we tested whether the cQTLs were
strongly correlated with other SNPs that alter the protein struc-
ture of any genes. Using the HaploReg SNP annotation tool
Figure 4. Genome-wide Significant Cytokine QTLs and Their Shared Association
(A) A circular Manhattan plot showing the 17 independent genome-wide significant loci associated with different cytokine levels. The cytokine name, type of
stimuli, and the top SNP rs ID is given. Loci that affect fungal-induced cytokines are shown in pink; loci that affect bacterial-induced cytokines are in blue; loci that
affect TLR-ligand-induced cytokines are in green.
(B) The association results of all 17 genome-wide significant cQTLs with all the available cytokine measurements are shown. The color key indicates the range of
cQTL p values (shown as log10 p value) from p < 0.01 to p < 5 3 1023. Red indicates the minor allele associated with higher levels of cytokines, while blue
indicates theminor allele associated with lower levels of cytokines. The x axis shows all 17 genome-wide significant loci, and the y axis shows the cytokine-stimuli
pairs. WB, whole blood.
See also Figure S3 and Tables S2 and S3.(Ward and Kellis, 2012), we extracted all SNPs in linkage disequi-
librium (LD) (R2 > 0.8; using the CEU population as a reference)
with the cQTLs. We found two loci that were in strong LD
with missense variants (Table S3): SNPs rs28393318 and
rs6834581 on chromosome 4 were in strong LD (R2 = 0.97,D prime = 0.99) with a missense variant, rs4833095, on the
TLR1 gene. SNP rs7256586 on chromosome 19 was in strong
LD with a missense variant rs198977 (R2 = 0.82, D prime =
0.92) on the KLK2 gene. These observations suggest that
TLR1 and KLK2 could be causal genes at these cQTL loci. TheCell 167, 1099–1110, November 3, 2016 1103
Table 1. Genome-Wide Significant Cytokine QTL Loci
Locus SNPs Chromosome Base Pair Stimulation Cytokine
Cell
System Time p Valuea Causal Genes
1 rs891372 1 207414046 C. burnetii IL-6 PBMC 24 hr 3.2 3 109 CD55b,c and CR2b,c
2 rs4496335 2 113844475 Cryptococcus TNF-a PBMC 24 hr 4.2 3 109 IL1RNb
3 rs9941692 2 153183071 C. burnetii IL-6 PBMC 24 hr 3.7 3 1010 FMNL2b and STAM2c
4 rs28393318 4 38784267 Poly(I:C) IL-1b PBMC 24 hr 2.8 3 1011 TLR1b,c,d, TLR6b,c, TLR10b,c,
and FAM114A1brs6834581 4 38788234 C. burnetii IL-1b PBMC 24 hr 4.6 3 1013
rs6834581 4 38788234 Poly(I:C) IL-6 PBMC 24 hr 3.9 3 1025
5 rs351250 5 141286682 C. burnetii IL-6 PBMC 24 hr 3.3 3 108 SLC25A2b, PCDH12b, and
KIAA0141c
6 rs543772713 7 6742260 C. albicans TNF-a PBMC 24 hr 4.2 3 108 ZNF12e
7 rs10108108 8 5056750 C. albicans IL-22 T cell 7 days 1.5 3 108 CSMD1e
8 rs10959009 9 10278031 C. burnetii IL-6 PBMC 24 hr 3.9 3 108 PTPRDc
9 rs17615278 10 36600213 Borrelia IFN-g T cell 7 days 3.9 3 108 RP11-92J19.3e and RP11-
810B23.1e
10 rs2350821 10 86927851 LPS IL-1b PBMC 24 hr 1.3 3 108 RP11-181F12.1e
11 rs10908219 11 69602333 Cryptococcus IFN-g T cell 7 days 1.0 3 108 FGF19e, FGF4e, FGF3e, and
MIR3164b
12 rs11020229 11 93000542 S. aureus IL-22 T cell 7 days 2.4 3 109 SLC36A4b,c
13 rs10790723 11 124961985 C. burnetii IL-1b PBMC 24 hr 1.0 3 108 SLC37A2b,c and AP001007.1b
14 rs7310164 12 56185207 C. burnetii IL-6 PBMC 24 hr 4.7 3 109 ITGA7b,c, CD63c, and MMP19b
15 rs11103976 12 86908614 Borrelia IFN-g T cell 7 days 9.2 3 109 MGAT4Ce
16 rs4491463 15 36645770 E. coli TNF-a PBMC 24 hr 1.2 3 1010 RP11-47513.1e and
RP1147513.2e
17 rs7256586 19 51390809 C. albicans IL-6 Blood 48 hr 8.5 3 109 KLK2d and KLK4e
aCytokine QTL p values are derived after correcting for age, gender, and cell-count levels.
bExpression QTL results in blood show a correlation between cytokine QTL SNP and the expression of that gene.
cThe gene is differentially expressed in response to microbial stimulation in PBMCs.
dCytokine QTL SNP is in linkage disequilibrium with a missense variant within that gene.
eThe closest gene to the cytokine QTL is shown.other 15 cQTLs and their proxies are all located in non-coding re-
gions of the genome, suggesting a possible regulatory function
of cQTL loci.
As a second approach, we performed cis-eQTL mapping us-
ing RNA-sequencing (RNA-seq) data and genotype data from
629 healthy-donor blood samples (LifeLines-Deep cohort)
(Rican˜o-Ponce et al., 2016; Tigchelaar et al., 2015) as well as
eQTL results obtained from publicly available datasets provided
by HaploReg (Ward and Kellis, 2012).
As a third approach, we hypothesized that the genes that are
differentially regulated in response to different microbial stimuli
are the potential causal genes at our cQTL loci. To test this, we
extracted all the genes, including the non-coding genes, located
in a 500-kb cis-window of the 17 cQTLs and tested their expres-
sion in PBMCs stimulated with different microbial antigens (Fig-
ure S3C). By combining these three approaches, we identified 21
putative causal genes in 12 of the loci (Table 1). In the remaining
five loci, the gene nearest to the cQTL SNP is shown. Intriguingly,
the genes we identified by these three approaches were all
regulatory genes modulating cytokine production, rather than
eQTLs directly modulating the transcription of cytokine genes
and the production of cytokines themselves. The identified
genes were mainly involved in microbial sensing (TLR1, TLR6,1104 Cell 167, 1099–1110, November 3, 2016TLR10, CSMD1, CD63, CR2, and CD55), processing molecules
(SLC36A4 and SLC37A2), endoplasmic reticulum organization,
and cytokine signaling (IL1F10, IL1RN, and STAM2).
TLR1-TLR6-TLR10 Locus Is Associated with Cytokine
Production Capacity for Diverse Stimulations
The strongest association among the 17 cQTL loci was at the
TLR1-TLR6-TLR10 locus (Figures 5A and 5B) on chromosome
4, influencing poly(I:C)-induced IL-6 (p = 3.93 3 1025) and IL-
1b levels (p = 2.47 3 1010) in PBMCs. This locus also showed
significant association with Coxiella burnetii-induced IL-1b
(p = 4.62 3 1013) and TNF-a (p = 7.59 3 108) levels, as well
as moderate association with 20 different cytokine levels
(false-discovery-rate [FDR]-corrected p < 0.05) in response to
multiple other microbial stimulations (Figure 4B). This locus
was also found to be under strong evolutionary selection (dis-
cussed later). Since we also had full transcriptomics data ob-
tained by RNA-seq on PBMCs from 70 healthy individuals in
the Lifelines-Deep cohort (Tigchelaar et al., 2015) stimulated
with Candida albicans, we were able to construct co-expression
networks for the various alleles of the TLR1-TLR6-TLR10 locus.
Our pathway analysis showed an interesting differential induc-
tion of genes that are important for cytokine regulation and
Figure 5. Regional Association Plots and Boxplots for Cytokine QTLs
(A–D) Regional association plots at (A) the TLR10-TLR1-TLR6 locus associated with poly(I:C)-induced IL-6 levels and (C) the IL1F10-IL1RN locus associated with
Cryptococcus-induced TNF-a levels. The corresponding p values (as log10 values) of all SNPs in the region were plotted against their chromosomal position.
Estimated recombination rates are shown in blue to reflect the local LD structure (based on the CEU population) around the associated top SNP and its correlated
proxies (with bright red indicating highly correlated and pale red indicating weakly correlated). Boxplots in (B) and (D) show the genotype-stratified cytokine levels
for the TLR and IL1RN loci, respectively.
See also Figures S4 and S5.dependent on the cytokine-inducing allele (rs6834581*C) or the
alternative allele (rs6834581*T) (Figure S4). Many of these differ-
entially regulated genes have been shown to be important for
cytokine regulation; for example, TREML4 encodes for a protein
crucial for TLR7 signaling and antiviral defense (Ramirez-Ortiz
et al., 2015), and SCGB3A1 encodes for the cytokine-like secre-
toglobin family 3Amember 1 (or HIN-1), which plays an important
role in lung inflammation (Yamada et al., 2009).IL1F10-IL1RN Locus Is a Shared QTL for Cryptococcus-
and Influenza-Induced Cytokines
We found a significant cQTL for TNF-a levels in response
to Cryptococcus (Figures 5C and 5D) on chromosome 2
(p = 4.223 109). The same SNP (rs4496335) also has an effect
on the expression of genes in the IL-1F10-IL1RN locus that en-
codes the IL-1 receptor antagonist. This locus also showed
moderate association with IL-6 (3.38 3 106) and IL-1b levelsCell 167, 1099–1110, November 3, 2016 1105
(5.51 3 106) in response to Cryptococcus. IL-1Ra is a known
natural antagonist of the IL-1 receptor pathway, but it was not
knownwhether this also influencesCryptococcus-induced cyto-
kine production. In order to validate this finding, we performed a
series of experiments in which we show that pre-incubation of
PBMCs with IL-1Ra significantly inhibits the induction of cyto-
kines by Cryptococcus (Figure S5A). This is the only locus
in our 17 cQTL loci that was also moderately associated with
influenza-induced TNF-a, IL-1b, and IL-6 levels (Figure 4A).
Unsupervised clustering analysis of cytokines (Figure 2A)
showedmuch stronger similarities between influenza- andCryp-
tococcus-induced responses than between Cryptococcus and
other fungi-induced responses, suggesting that these two path-
ogens activate similar inflammatory pathways. This association
warrants further study.
CSMD1 and SLC36A4 Loci Specifically Regulate T
Cell-Derived Cytokines
We quantified three T cell-derived cytokines (IL-22, IL-17, and
interferon [IFN]-g) after stimulating PBMCs for 7 days with
various stimuli. We found three genome-wide significant loci
for IFN-g and two for IL-22 levels (Table 1). The strongest
association in these five loci was at the SLC36A4 locus on chro-
mosome 11 (Figures S5B and S5C), with Staphylococcus
aureus-induced IL-22 levels (p = 2.42 3 109). SLC36A4 en-
codes for an amino-acid transporter with a high affinity for
glutamine, tryptophan, and proline (Pillai and Meredith, 2011).
Amino-acid metabolism (especially tryptophan and glutamine)
has been reported to modulate cytokine production (Bosco
et al., 2000; Coe¨ffier et al., 2001; Harden et al., 2015). We vali-
dated this pathway in our study by showing that blocking
glutaminolysis with BPTES (bis-2-(5-phenylacetamido-1,3,4-
thiadiazol-2-yl)ethyl sulfide) significantly inhibits S. aureus-
induced IL-22 production (Figure S5D). The other cQTL for
C. albicans-induced IL-22 levels was found on chromosome 8
(p = 2.42 3 109) on the CSMD1 gene. CSMD1 encodes a pro-
tein that functions as a complement inhibitor (Escudero-Esparza
et al., 2013), and recent studies have shown that IL-22 and the
complement pathway influence each other and synergize during
host defense against pathogens (Yamamoto and Kemper, 2014).
The importance of the complement pathway for modulating
cytokine production is underscored by the presence of CR2
and CD55 among the genes whose genetic variation regulates
cytokine production (Table 1).
Finally, we tested whether the five independent T cell cytokine
QTLs were also associated with other cytokines. Although they
were moderately associated with cytokines produced in
response to other types of stimuli (e.g.,Mycobacterium tubercu-
losis, Cryptococcus; see Table 1), CSMD1 and SLC36A4 loci
were specifically associated with IL-22 and IFN-g production
capacity.
KLK2-KLK4 Locus Is Significantly Associated with IL-6
Levels in Whole-Blood Stimulation
We quantified IL-6, IL-1b, TNF-a, and IFN-g after stimulating
whole blood for 48 hr with various stimuli. We identified one locus
on chromosome 19 as significantly associated (p = 8.503 109)
with C. albicans-induced IL-6 levels. This locus encodes for kal-1106 Cell 167, 1099–1110, November 3, 2016licrein-related peptidases 2 and 4 (KLK2 and KLK4); the latter
has been described as inducing IL-6 production through activa-
tion of protease-activated receptor 1 (PAR-1), a well-known
immune-activated receptor (Wang et al., 2010). This locus is
also moderately associated with both monocyte- and T cell-
derived cytokines in response to multiple microbial stimulations
(Figure 4A).
cQTLs Are Enriched for Regions under Positive
Selection and Monocyte-Specific Enhancers and Are
Associated with Complex Human Diseases
Some of the cQTL loci were common to several stimuli, but many
were stimulus specific (Figure 4B). This finding supports the
conclusion that the cytokine response is evolutionarily built
around the response to specific pathogens, a process most
likely shaped by the selective evolutionary processes exerted
by local infections in certain geographical locations. This is
also supported by our observation that the cQTL genes are un-
der strong selective pressure. We intersected our 17 cQTLs
with the regions in the human genome catalogued as ‘‘loci under
positive selection’’ in 230 ancient Eurasian genomes (Mathieson
et al., 2015). Our cQTLs were significantly enriched (Kolmo-
gorov-Smirnov test, p value < 0.01) for ‘‘genes under positive
selection’’ in the Eurasian genomes (Figure 6A), including the
well-known TLR1-TLR6-TLR10 and LCT loci.
The fact that themajority of the cQTL loci were in LDwith SNPs
in non-coding regions means that they could have regulatory
functions. Therefore, we intersected these 17 top cQTLs and
their proxies (r2 % 0.8) with the ENCODE-defined cell-type-
specific enhancers. This showed a significant enrichment of
these cQTLs in monocyte-specific enhancers (Figure 6B), sug-
gesting that many of the cQTLs influence gene expression in
monocytes and, thereby, alter cytokine production. We also
tested whether the 17 cQTLs are associated with human dis-
eases. We intersected the cQTLs with GWAS SNPs known to
influence susceptibility to various immune-mediated diseases.
Interestingly, SNPs that affect monocyte-derived cytokines are
also enriched for SNPs associated with infectious diseases (Fig-
ure 6C). In contrast, cQTLs that affect T cell-derived cytokines
are enriched for SNPs associated with autoimmune diseases
(Figure 6D). In addition, we identified a trend for the association
of cQTLs with SNPs associated with other complex human phe-
notypes, such as blood-related traits and cancer (Figure 6E).
These results suggest that proinflammatory cytokines have an
important role as underlying mediators in many complex human
diseases.
DISCUSSION
In three complementary studies in this issue ofCell, we report on
the impact of genetic (the present study), environmental (ter
Horst et al., 2016), andmicrobiome (Schirmer et al., 2016) factors
on the cytokine production capacity in a large cohort of healthy
individuals of Western European background. The present study
is broad both at the genomic level (8 million SNPs) and at a func-
tional level: we assessed three types of cellular stimulation
models (whole blood, PBMCs, and monocyte-derived macro-
phages) challenged with a comprehensive panel of bacterial,
Figure 6. Cytokine QTLs Are Enriched for
Human Diseases
(A) A Q-Q plot showing the enrichment of cytokine
QTLs is under positive selection. The cytokine
QTLs were intersected with loci under positive
selection and tested for their inflation compared to
a randomly selected set of SNPs.
(B) Impact of genome-wide significant cytokine
QTLs on human diseases. All 17 cQTL loci and their
proxies (R2 > 0.8) were intersected with cell-type-
specific enhancers from the ENCODE project. The
x axis depicts the log10 binomial uncorrected
p values; the y axis shows the different cell types.
The dotted gray line indicates the significance
threshold after Bonferroni correction for the num-
ber of cell types tested. Different colors indicate the
two sets of background SNPs included for testing
enrichment of cQTLs located in any cell-type-
specific enhancers.
(C and D) The percentages of SNPs associated
with (C) infectious disease and (D) immune-medi-
ated diseases that affect either monocyte-derived
or T cell-derived cytokines levels are shown.
(E) The percentage of disease-associated SNPs
showing suggestive cytokine QTLs. GWAS SNPs
and their proxies from each disease were
compared to SNPs associated with ‘‘height,’’ a trait
serving as a reference (null) set. The p values of
enrichment analysis from Fisher exact tests are
indicated by asterisks (**p < 104). T2D, type 2
diabetes.fungal, viral, and non-microbial metabolic stimuli. The data pre-
sented here support the hypothesis that genetic variation is one
of themain factors influencing cytokine responses, with variation
of several cytokines, especially the IL-1b/IL-6 pathway, being
mainly regulated by genetic factors (Figures S6 and S7). In line
with this, we identify 17 new genome-wide significant loci that in-
fluence cytokine production, and we provide genetic and func-
tional validation for their biological importance.
The conclusion that there is a high genetic heritability of cyto-
kine production capacity in the context of microbial stimulation is
supported by a recent study showing a strong genetic compo-
nent in the regulation of multiple immune traits in twins (Roederer
et al., 2015). The genes we identify as cytokine regulators can be
grouped into two processes: (a) innate immune genes, such as
the pattern recognition receptors (e.g., the TLR1/6/10 cluster),
and complement modulators; and (b) genes important for anti-
gen processing in the endoplasmic reticulum. Among this last
groups of genes, one of them (SLC36A4) is also an amino acid
transporter, particularly for tryptophan, proline, and glutamineCe(Pillai and Meredith, 2011), and we have
here validated the role of glutamine
metabolism in the induction of IL-22
responses.
The identification of cell-type-depen-
dent cQTLs and their potential relevance
for infectious and autoimmune diseases
in humans is of considerable interest.
Our results imply that monocyte-derivedcQTLs are associated to a susceptibility to infections, while
T cell-derived cQTLs overlap with loci associated to autoimmune
diseases. This result has important implications, as it provides a
model to gain insight into the mechanistic basis of disease asso-
ciations in a cell-type-specific manner. This important finding is
underpinned by another HFGP study by Aguirre-Gamboa et al.
(2016), which describes cell-count QTLs that influence lympho-
cyte numbers being associated with susceptibility to autoim-
mune diseases. We were also able to further dissect the impact
of the various cQTLs for different pathologies and have, for
example, gained important new insight into the preferential
impact of monocyte-derived cQTLs for blood-related (hemato-
logical) diseases, while these are seen to be less strongly
involved in autoimmune diseases or cancer.
We also extracted additional important biological properties
characterizing cytokine responses. First, we observed a surpris-
ingly small impact of cell numbers on cytokine production ca-
pacity, even in the case of whole-blood stimulation, with only a
few exceptions showing a moderate impact. This conclusion isll 167, 1099–1110, November 3, 2016 1107
supported by the results of a previous study published by our
group (Li et al., 2016) and demonstrates that the most important
impact on cytokine secretion is determined by the intrinsic
cellular characteristics. Second, we identified an important
pattern in the architecture of cytokine responses: the production
capacity of various monocyte-derived or lymphocyte-derived
cytokines correlated strongly when cells were stimulated with a
specific pathogen, whereas the correlation was poor when
comparing bacterial stimuli with fungal and viral stimuli. This
makes sense from an evolutionary point of view, as immune re-
sponses mainly need to have plasticity to respond to specific in-
fectious pressures in any given geographic area (Netea et al.,
2012). This conclusion is supported by the enrichment of cQTL
genes among the genes recently reported to be under selection
in Eurasian populations (Mathieson et al., 2015). Finally, nearly all
the cQTLs described here are trans-QTLs, and they were signif-
icantly enriched in monocyte-specific enhancers. This suggests
that many cQTLs influence the expression of target genes in
monocytes to alter cytokine production indirectly.
There are also a number of limitations to the present study. It is
possible that we may have underestimated the heritability of
cytokine responses by performing a SNP-based analysis. To
address this aspect, it will be interesting in the future to assess
the heritability of cytokine responses using longitudinal data,
as this will allow us to take other factors (e.g., seasonal variation)
into account. Moreover, future twin-based studies could take
the stimulation aspect into account when performing the herita-
bility estimation of immune parameters. In addition, although
this is the most comprehensive study on cytokine production
in humans so far, the number of cytokines measured is still
relatively limited. We have chosen to study the most important
proinflammatory cytokines produced by monocytes, Th1 and
Th17 cells; however, future studies should also include other
classes of cytokines, such as anti-inflammatory cytokines,
IFNs, or chemokines.
In conclusion, we present a comprehensive analysis of how
genetic variation affects cytokine production capacity in hu-
mans. Our study should be considered in the broader framework
of the HFGP, in which environmental, non-genetic host factors
and the microbiome have also been shown to influence immune
responses (see the accompanying studies by ter Horst et al.,
2016, and Schirmer et al., 2016, in this issue). In a first study,
we show that age is an important factor, with a specific defect
of IFN-g and IL-22 production in the elderly (ter Horst et al.,
2016): future studies in a population of elderly individuals should
assesswhether the genetic factors identified here also play a role
in this process. Similarly, gender and seasonality also influence
immune responses. In addition, the accompanying study by
Schirmer et al. demonstrates the impact of microbiome vari-
ability on cytokine responses. Although it is important to note
that the microbiome has an important role, it does seem to
have a smaller impact on cytokine production than host genetic
factors: while we observe here a 25% to 75% genetic heritability
for most of the cytokines mentioned, the microbiome variation
explains up to 10% of the cytokine production capacity
(Schirmer et al., 2016).
However, the genomic variation may act either directly or indi-
rectly through impactingonother factors, e.g., themicrobiome. In1108 Cell 167, 1099–1110, November 3, 2016this respect, recent studies have reported host genetic factors
that influence the microbiome (Bonder et al., 2016; Davenport
et al., 2015; Goodrich et al., 2016; Knights et al., 2014): future
studies in theHFGPplan to integrate the complex patient-related
and omics databases into comprehensive models to explain
cytokine production and other complex immune traits. These
complementary studieswill be important in understanding the in-
fluences on human cytokine responses and their variation and
canbe used to pinpoint factors that can bemodified and targeted
for the personalized treatment of immune-mediated diseases.
Finally, the HFGP in general, and these three studies reported
in this issue of Cell in particular, offer an important methodology
beyond the analyses of cytokine responses, because they pro-
vide a framework for future functional genomics studies looking
to assess immune and non-immune biological processes.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
ProlastinC (AAT) Grifols N/A
BSA SIGMA A7030
Critical Commercial Assays
Human IL-1beta ELISA Kit RD Systems DY201
Human IL-6 ELISA Kit PeliKine Compact M9316
Human TNF-a ELISA Kit RD Systems DY210
Human IL-22 ELISA Kit RD Systems DY782
Human IL-17 ELISA Kit RD Systems DY317
Human IFNg ELISA Kit PeliKine Compact M9333
Human AAT ELISA Kit RD Systems DY1268
Human Resistin ELISA Kit RD Systems DY1359
Human Leptin ELISA Kit RD Systems DY398
Human Adiponection ELISA Kit RD Systems DY1065
Human IL-1Ra ELISA Kit RD Systems DRA00B
Human IL-18Bp ELISA Kit RD Systems DY119
IgM,IgG,IgA Beckman Coulter In house
IgG subclasses Binding Site BN II Combi Kit
25-hydroxy vitamin D3 measurement LCMSMS In house
Testosterone measurement LCMSMS In house
Progesterone measurement LCMSMS In house
Plasma IL-1beta Protein Simple Simple Plex cartridges
Plasma IL-6 Protein Simple Simple Plex cartridges
Plasma IL-18 Protein Simple Simple Plex cartridges
Plasma VEGF Protein Simple Simple Plex cartridges
Mouse IL-1beta RD Systems DY401
TruSeq RNA sample preparation kit v2 Illumina RS-122-2001
Deposited Data
ELISA cytokine measurents and other
cohort data:
This paper/ BBMRI-NL data infrastructure https://hfgp.bbmri.nl/;
http://bbmri-eric.eu/bbmri-eric-directory
RNA sequencing of 88 individuals This paper/ BBMRI-NL data infrastructure https://hfgp.bbmri.nl/









Human PBMCs and Human Monocytes Primary/Healthy volunteers N/A
Bacteroides fragilis BD Biosciences, Franklin Lakes NCTC 10584
E. coli N/A ATCC 25922
Staphylococcus aureus N/A ATCC 29213
LPS Sigma-Aldrich, St. Louis E. coli serotype 055:B5
Mycobacterium tuberculosis N/A H37Rv
C. burnetii Bundeswehr Institute for Microbiology,
Munich
Nine Mile RSA493
B. burgdorferi N/A ATCC strain 35210
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
C. albicans blastoconidia N/A strain ATCC MYA-3573, UC 820
Aspergillus fumigatus N/A V05-27
Cryptococcus gattii N/A A1M-R265, AFLP type 6
Influenza virus N/A pH1N1 A/Netherlands/602/09




Life Technologies Globin Clear kit Illumina www.illumina.com
Paired End cluster kit llumina www.illumina.com
HiSeq2500 SBS Sequencing reagents llumina www.illumina.com
Infinium CoreExome-24 v1.1 kit Illumina www.illumina.com
Software and Algorithms
R programming language R Development Core Team, 2015.
R: A language and environment for
statistical computing. R Foundation for
Statistical Computing, Vienna, Austria.
https://www.R-project.org/
Custom scripts in the r programming
language based on function like: lm {stats},
cor {stats}, cor.test {stats}
R Development Core Team, 2015.
R: A language and environment for
statistical computing. R Foundation for
Statistical Computing, Vienna, Austria.
https://www.R-project.org/
RNA sequencing mapping: STAR
(version 2.3.0)
Dobin et al., 2013 https://github.com/alexdobin/STAR
RNA read counting: HTSeq
(version 0.5.4p3)
Anders et al., 2015 http://www-huber.embl.de/users/anders/
HTSeq/doc/overview.htmlCONTACT FOR REAGENT AND RESOURCE SHARING
Request should be directed and will be fulfilled by lead author Y.L. (y.li01@umcg.nl).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Ethics statement
The HFGP study was approved by the Ethical Committee of Radboud University Nijmegen, the Netherlands (no. 42561.091.12). Ex-
periments were conducted according to the principles expressed in the Declaration of Helsinki. Samples of venous bloodwere drawn
after informed consent was obtained.
Population cohorts
The study was performed in two independent cohorts of 500 and 200 healthy individuals of Western European ancestry from the
Human Functional Genomics Project (500FG and 200FG cohorts, see www.humanfunctionalgenomics.org). The 500FG cohort com-
prises 534 adults fromNijmegen, the Netherlands (237males and 296 females, age range 18–75 years). The 200FG cohort comprises
Individuals from the ‘Geldersch Landschap’, ‘Hoge Veluwe’, ‘Twickel’, and ‘Kroondomein het Loo’ in the Netherlands (77% males
and 23% females, age range 23-73 years old).
Stimuli
Bacteria
Bacteroides fragilis (NCTC 10584) grown anaerobically overnight at 37C on blood agar plates (BD Biosciences, Franklin Lakes) was
inoculated in 20 mL pre-warmed and pre-reduced Brain Heart Infusion broth (BD Diagnostics, Basel) and again grown anaerobically
overnight at 37C until reaching a stationary growth phase mimicking growth conditions in abscesses. Bacterial suspensions were
washed three times in phosphate-buffered saline (PBS; B. BraunMedical B.V., Melsungen) and heat-killed at 95C for 30min. Beforee2 Cell 167, 1099–1110.e1–e6, November 3, 2016
heat-killing, aliquots of bacterial suspensions were taken to determine colony-forming unit (CFU) counts. Heat-killed bacteria were
washed again and after adjusting the concentration in PBS to 13 108 CFU/mL, stored at –80C.B. fragiliswas used in the stimulation
experiments as 1 3 106/mL.
E. coli ATCC 25922 was grown overnight in culture medium, washed three times with PBS, and heat-killed for 60 min at 80C.
Staphylococcus aureus strain ATCC 29213 was grown overnight in culture medium, washed twice with cold PBS, and heat-killed
for 30 min at 100C; both E. coli and S. aureus were used in a final concentration of 1 3 106/mL. Success of heat-inactivation
was confirmed by cultures.
LPS (E. coli serotype 055:B5), a TLR4 ligand, was purchased from Sigma-Aldrich (St. Louis) and an extra purification step was per-
formed as described previously (Hirschfeld et al., 2000). Purified LPS was tested in TLR4/mice for the presence of contaminants
and did not show any TLR4-independent activity. CpG (ODN M362) was purchased from InvivoGen (San Diego) and used at a final
concentration of 10 mg/mL.
Cultures of H37Rv Mycobacterium tuberculosis (MTB) were grown to mid-log phase in Middlebrook 7H9 liquid medium (Difco,
Becton Dickinson, East-Rutherford) supplemented with oleic acid/albumin/dextrose/catalase (OADC) (BBL, Becton Dickinson),
washed three times in sterile saline solution, heat-killed and then disrupted using a bead beater, after which the concentration
was measured using a bicinchoninic acid (BCA) assay (Pierce, Thermo Scientific, Rockville).
C. burnetii Nine Mile RSA493 (NM) phase I (a gift from the Bundeswehr Institute for Microbiology, Munich, Germany) was cultured
on buffalo green monkey cells, and the numbers of Coxiella DNA copies were determined using TaqMan real-time polymerase chain
reaction as described (Roest et al., 2012). Lipopolysaccharide (LPS) phase determination was performed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis and silver staining, using purified phase I (RSA493) and phase II (RSA439) C. burnetii NM LPS
(kindly provided by R. Toman) as controls (Hitchcock and Brown, 1983; Schramek and Galanos, 1981). C. burnetii was inactivated
by heating for 30 min at 99C.
B. burgdorferi, ATCC strain 35210, was cultured at 33C in Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) supple-
mentedwith 6% rabbit serum. Spirochetes were grown to late-logarithmic phase and examined formotility by dark-fieldmicroscopy.
Organisms were counted using a Petroff-Hauser counting chamber. Bacteria were harvested by centrifugation of the culture at
3000 g for 30 min, washed twice with sterile PBS (pH 7.4), and diluted in the specified medium to the required concentrations of
1 3 106 spirochetes per mL. The serum-resistant Salmonella typhimurium strain (phage type 510) was grown at 37C for 12 hr in
nutrient broth (BHI Oxoid, Nepean). Bacteria were collected and centrifuged and then washed three times in PBS. Aliquots were
stored at –20C throughout the study.
Fungi
Heat-killed C. albicans blastoconidia (strain ATCC MYA-3573, UC 820) in a concentration of 106 CFU/mL were used throughout
this study. A clinical isolate of Aspergillus fumigatus V05-27 was used for stimulations. Isolates were grown on YAG agar plates
for 3 days at 37C. Fungal spores in the presence of sterile 0.1% Tween 20 in PBS were harvested by gentle shaking, washed
twice with PBS, filtered through a 40-mm pore size cell strainer (Falcon, Vienna) to separate conidia from contaminating
mycelium. They were then counted by a hemacytometer, suspended at a concentration of 108 spores/mL and heat-killed. A final
concentration of 1 3 107/mL was used in the experiments. A clinical isolate of Cryptococcus gattii (A1M-R265, AFLP type 6)
was freshly grown on Sabouraud dextrose agar plates. Afterward a suspension in PBS was heat-killed at 56C for 24 hr and
then quantified at a wavelength of 530 nm on a spectrophotometer. Killing efficiency as well as bacterial and fungal contami-
nation was checked using Sabouraud dextrose and blood agar plates, respectively. Aliquots were stored at –20C throughout
the study.
Influenza virus culture and inactivation. Influenza virus strain pH1N1 A/Netherlands/602/09 (kindly provided by Prof. Ron Fouchier,
Erasmus MC, Rotterdam) was grown in the allantoic fluid of embryonated chicken eggs. Viral titers were determined by three inde-
pendent plaque assays performed on Madin-Darby canine kidney (MDCK) cells. To inactivate the pH1N1 strain, b-propiolactone
(BPL) (Acros Organics, Morris Plans) in citrate buffer (125 mM sodium citrate, 150 mM sodium chloride [pH 8.2]) was added to
the pH1N1 virus to a final concentration of 0.1% and incubated for 24 hr at 4C under continuous slow shaking. Inactivated virus
was subsequently snap-frozen and stored at –80C. Virus inactivation was confirmed by three passages in MDCKs where no virus
could be detected by plaque assay following the third passage.
TLR ligands and non-microbial stimuli
Pam3Cys, a TLR1/2 ligand, was purchased at EMC microcollections (L-2000) and used in a final concentration of 10 mg/mL.
PolyI:C, a TLR3 ligand, was purchased from InvivoGen and used at a final concentration of 100 mg/mL. PHA was purchased from
Sigma and used at a final concentration of 10 mg/mL. Palmitic acid was purchased from Sigma-Aldrich. Human albumin (Albuman)
was purchased from Sanquin (Amsterdam). Stock palmitic acid was dissolved in 100% ethanol. Palmitic acid (C16.0) and human
albumin were conjugated by warming to 37C in a water bath before adding together in a 1:5 ratio. The mixture was sonicated for
20–25 min and kept at 37C until use. The vehicle control for 50 mM C16.0 consisted of 0.025% albumin and 0.025% ethanol.
MSU crystals were formed by dissolving 1.0 g of uric acid and 0.48 g sodium hydroxide in 400 mL of sterile water. The pH was
adjusted to 7.2 and the solution was sterilized by heating it for 6 hr at 120C. No LPS contamination was detected by Limulus amoe-
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METHOD DETAILS
PBMC collection and stimulation experiments
After obtaining informed consent, venous blood was drawn from the cubital vein of volunteers into 10 mL EDTA Monoject tubes
(Medtronic, Dublin). The PBMC fraction was obtained by density centrifugation of EDTA blood diluted 1:1 in pyrogen-free saline
over Ficoll-Paque (Pharmacia Biotech, Uppsala). Cells were washed twice in saline and suspended in medium (RPMI 1640) supple-
mentedwith gentamicin (10mg/mL), L-glutamine (10mM) and pyruvate (10mM). Addition of antibiotics such as gentamycin is a stan-
dardmethod used to avoid contamination of cultures, and it does not influence the ability to induce cytokine production by PBMCs or
macrophages (data not shown). The cells were counted in a Coulter counter (Beckman Coulter, Pasadena) and the number was
adjusted to 53 106 cells/mL. A total of 53 105 PBMCs in a total volume of 200 mL per well were incubated at 37C in round-bottom
96-well plates with the different stimuli, as indicated above. After 24 h (for early cytokines IL-1b, TNF-a, IL-6, IL-8, and IL-10), or
7 days of incubation (for IFN-g and IL-17), supernatants were collected and stored at –20C until assayed. The stimulation periods
were chosen based on extensive studies that showed that 24 hr stimulation was best suited for assessing monocyte-derived cyto-
kines. When cells were cultured for 7 days, this was done in the presence of 10% human pooled serum.
For validation experiments, PBMCswere incubated with recombinant IL-1Ra (R&D Systems, Minneapolis) 10 mg/ml, 30 min before
stimulation with C. neoformans. The cytokine production capacity in the absence or presence of IL-1Ra was measured in the super-
natants as described above.
Macrophage differentiation and stimulation
We cultured > 53 105 monocytes in flat-bottom plates with 10% human serum at 37C and 5%CO2 for 6 days. After differentiation,
the medium was removed and the differentiated macrophages were stimulated for 24 hr. Supernatants were collected and stored
in –20C until used for ELISA.
Whole-blood stimulation experiments
100 mL of heparin blood was added to a 48-well plate and then stimulated with 400 mL stimulus (final volume 500 ml) for 48 hr at 37C
and 5%CO2. Supernatants were collected and stored in –20
C until used for ELISA.
Cytokine measurements
Concentrations of human IL-1b, IL-6, IL-10, TNF-a, IL-17, or IFN-g were determined using specific commercial ELISA kits (PeliKine
Compact, Amsterdam, or R&D Systems), in accordance with the manufacturer’s instructions. Detection limits were 31 pg/mL (IL-6
(macrophages), 39 pg/mL (IL-1b and IFNg), 156 pg/mL (IL-6 (whole blood), IL-22) or 78 pg/mL (TNF-a and IL-17).
Cytokine clustering and variance analysis
Raw cytokine levels were first log-transformed, and cytokine measurements showing little/no variation across individuals were
filtered out for the follow-up analysis. We excluded 17 stimulation-cytokine measurements that did not pass our quality control. Un-
supervised hierarchical clustering was performed using Spearman’s correlation as the measure of similarity. We used Levene’s test
to check the equality of variance of cytokine levels before and after stimulation.
Genotyping, quality control and imputation
DNA samples of 500 individuals were genotyped using the commercially available SNP chip, Illumina HumanOmniExpressExome-8
v1.0. The genotype calling was performed using Opticall 0.7.0 (Shah et al., 2012) using default settings. Samples with a call
rate % 0.99 were excluded from the dataset, as were variants with a Hardy-Weinburg equilibrium (HWE) % 0.0001, call
rate% 0.99 and minor allele frequency (MAF)% 0.001. We identified 17 ethnic outliers by merging multi-dimensional scaling plots
of samples with 1000Genomes data and these were excluded from further analysis (Figure S7). This resulted in a dataset of 483 sam-
ples containing genotype information on 518,980 variants for further imputation. The strands and variant-identifiers were aligned to
the referenceGenome of the Netherlands (GoNL, Genome of theNetherlands Consortium, 2014) dataset usingGenotypeHarmonizer
(Deelen et al., 2014a). The data were phased using SHAPEIT2 v2 (Delaneau et al., 2013) using GoNL as a reference panel. Finally,
these data were imputed using IMPUTE2 (Howie et al., 2011) with GoNL as the reference panel (Deelen et al., 2014b). We selected
SNPs that showed an INFO scoreR 0.8 upon imputation for further cytokine QTL mapping.
Cytokine QTL mapping
Both genotype and cytokine data could be generated for a total of 442 individuals.We obtained cell count datameasured by FACS for
total lymphocytes, T cells, B cells, monocytes and NK-cells from 487 individuals from the 500FG cohort. In total, there were 409 sam-
ples with genotype, cytokine, and cell-count data.We excluded 17 samples due to genetic differences.We coded gender information
either 0 for females or 1 for males. The actual age, gender, and cell-count information were included as covariables in the linear model
to correct the cytokine distributions for QTL mapping. Raw cytokine levels were first log-transformed then mapped to genotype data
using a linear regression model with age and gender as covariates. Since the stimulation-cytokine combinations cannot be regarded
as completely independent (we observed strong correlations in the cytokine clustering analysis we performed), the total number ofe4 Cell 167, 1099–1110.e1–e6, November 3, 2016
independent tests among all phenotypeswill bemuch less than the number of phenotypesmeasured, and therefore correcting for the
number of SNPs tested for each trait should be sufficient. We considered a p value of < 5 3 108 to be the threshold for significant
cytokine QTLs.
Cytokine heritability estimation
Using the GCTA tool (Yang et al., 2010), we fitted a linear mixed model to each of the 112 cytokine phenotypes and used restricted
maximum likelihood to estimate the variance explained by the approximately 8 million SNPs. Following our method for cQTL map-
ping, we also included age, gender, and cell counts as covariates for estimating the proportions of phenotypic variance explained by
the SNPs. It should be noted that the 95% confidence intervals for the heritability estimate are wide due to the sample size (N < 1000)
in this study (Zaitlen and Kraft, 2012).
Expression QTL analysis to prioritize causal genes
RNA sequencing of 629 peripheral blood samples from the LifeLines-Deep cohort (Tigchelaar et al., 2015) were investigated to map
cis-eQTLs. The eQTLmapping strategy and data have been described in detail (Rican˜o-Ponce et al., 2016). Briefly, cis-eQTL analysis
was performed on transcript-SNP combinations for which the distance from the center of the transcript to the genomic location of the
SNP was% 500 kb. Associations were tested by non-parametric Spearman’s rank correlation test and a p value < 0.05 was consid-
ered significant. We also employed HaploReg database v4.1 (Ward and Kellis, 2012) (www.broadinstitute.org/mammals/haploreg/
haploreg.php) to extract publicly available eQTL results from blood tissue for cytokine QTL SNPs.
Genotype-dependent gene expression analysis at rs6834581
The PBMCs from 70 individuals in the Lifelines-Deep cohort (Tigchelaar et al., 2015) were stimulated with or withoutCandida albicans
as previously described (Smeekens et al., 2013; Kumar et al., 2014b). The RNA sequencing analysis of this dataset has been
described by previously (Li et al., 2016). There were 7 CC, 25 CT and 38 TT individuals carrying these genotypes at rs6834581.
We combined CC and CT in one group and compared the median expression-fold changes of genome-wide transcripts between
two genotype groups (CC+CT versus TT).We focused on the absolute fold changes between these two groups and show the expres-
sion levels of the top 30 genes in Figure S4.
Candidate genes located within a cis-window of approximately 500 kb of all significant cytokine QTL loci were further tested to
see if they responded to any of the pathogens using RNA-seq data from PBMCs of eight individuals, which were stimulated by Pseu-
domonas aeruginosa, Streptococcus pneumoniae,Mycobacterium tuberculosis, Candida albicans, Aspergillus fumigatus, and IL-1a
(Li et al., 2016).
Intersection of ENCODE enhancers and regions under positive selection
To perform enhancer enrichment analysis on cytokine QTL SNPs, we extracted all proxies for the 17 cQTLs (R2R 0.8; CEU popu-
lation as a reference) to have 186 variants.We then intersected these variants with enhancer data of 127 different cell lines available in
HaploReg tool v4.1 (www.broadinstitute.org/mammals/haploreg/haploreg.php). HaploReg calculates a background frequency of
enhancer overlap in each cell type using two background sets of SNPs. It compares the data with all independent GWAS loci asso-
ciated in the European population, and with a second set of background SNPs consisting of all 1000 Genomes variants with a
frequency > 5%. Initial enrichment of enhancers is calculated using the Binomial test and we applied the Bonferroni correction for
multiple testing to define significance levels (0.05/127 cell lines).
Extraction of infectious disease associated SNPs
SNPs associated with a number of infectious diseases that showed a p value < 9.993 106 were extracted using the GWAS catalog
(http://www.genome.gov/gwasstudies). As of December 2014, there were two studies on leprosy, two studies on malaria, four
studies on tuberculosis, four studies on chronic hepatitis C infection, one study on HPV seropositivity, one study on Dengue shock
syndrome, and one study onmeningococcal susceptibility. From a systematic search of the literature, we extracted SNPs associated
with susceptibility to other infectious diseases but not reported in theGWAS catalog.We found three studies on invasive aspergillosis
and two studies on pneumococcal disease (see the list published in Li et al. (2016).
GWAS SNP extraction and enrichment analysis
GWAS SNPs from the GWAS catalog and their proxies (r2R 0.8 from a 500 kb window) were first extracted, which provided a list of
SNPs associated to 122 different human traits and diseases. We selected diseases/traits for which at least 10 independent SNPs
were reported to be associated.We then binned theseGWASSNPs into eight categories based on their association to closely related
human phenotypes (cancer, immune-mediated diseases, infectious disease, heart-related traits, blood-related traits, metabolic
traits, height, and Type 2 diabetes-related traits). Duplicated SNPs were removed from further analysis. We then intersected the
SNPs of each category with cQTLs that showed p < 0.05 in our study. The Fisher exact test was applied to test the over-represen-
tation of cQTL SNPs in infectious disease SNPs using the height-associated SNPs as reference.Cell 167, 1099–1110.e1–e6, November 3, 2016 e5
Enrichment for positive selection
The cytokine QTLs at different thresholds (13 107, 13 106, 13 105, 13 104) were intersected with loci under positive selection
(Mathieson et al., 2015). The distribution of positive selection p values on cQTL SNPs were compared with a randomly selected set of
non-significant cQTL SNPs (p > 0.01) by using Kolmogorov–Smirnov test.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed in R. Unsupervised hierarchical clustering was performed using Spearman’s correlation as the
measure of similarity. The Levene’s test to check the equality of variance of cytokine levels before and after stimulation. R-package
Matrix-eQTL, was used for cytokine QTL mapping, where linear model was applied with age, gender, and cell-count information
included as covariables. The Fisher exact test was applied to test the over-representation of cQTL SNPs in infectious disease
SNPs using the height-associated SNPs as reference.
DATA AND SOFTWARE AVAILABILITY
Online database
All data used in this project have been meticulously cataloged and archived in the BBMRI-NL data infrastructure (https://hfgp.
bbmri.nl/) using the MOLGENIS open source platform for scientific data (Swertz et al., 2010). This allows flexible data querying
and download, including sufficiently rich metadata and interfaces for machine processing (R statistics, REST API) and using
FAIR principles to optimize Findability, Accessibility, Interoperability and Reusability (Wilkinson et al., 2016).e6 Cell 167, 1099–1110.e1–e6, November 3, 2016
Supplemental Figures
Figure S1. Increased Levels of Cytokines upon Stimulation, Related to Figure 1
The box plots of 6 different cytokines in 500 individuals upon stimulation. The y-axis depicts the log2 transformed cytokine levels. The x-axis shows different
stimulations used to induce cytokine production in different tissues. The color legend indicates the different tissue systems used for stimulation.
Figure S2. Increased Inter-individual Variation upon Stimulation, Related to Figure 1
Box plots of cytokine levels (x axis) induced upon stimulation (y axis) in 500 individuals sorted based on the median values. The color legend shows the different
tissues used for stimulation.
(legend on next page)
Figure S3. Genome-wide Significant Cytokine QTLs, Related to Figure 4
(A) Correlation between PBMC-derived cytokines and cell counts.
(B) Summary of all genome-wide significant cytokine QTLs.
(C) Prioritized causal genes by differential expression analysis for genome-wide significant cytokine QTLs.
Figure S4. TLR1-6-10 Locus Genotype Stratified Gene Regulation upon Candida Stimulation, Related to Figure 5
Figure S5. Cytokine QTLs for TNF and IL22 Production, Related to Figure 5
(A) Validation of Cryptococcus induced cytokine TNF production.
(B) Regional plot of the association of SLC36A4 locus with S. aureus induced IL-22 levels in PBMCs.
(C) Boxplot of S. aureus induced IL-22 levels in PBMCs at SLC36A4 locus.
(D) Validation of S. aureus induced cytokine IL22 production
Figure S6. Proportion of Explained Variance of Cytokine Levels by Genetics, Across All the Measurements, Related to Figure 3
A summary of all the estimates of cytokine variance explained by genome-wide SNP data after age, gender, and cell-count correction is shown. The estimates
<25% are shown in gray, and the estimates >50% are shown in black.
Figure S7. Multidimensional Scale Analysis of Genotype Data from 500FG Cohort, Related to Figures 3 and S6 and STAR Methods
Genome-wide SNP data was used to perform multidimensional scaling analysis across different populations, including 500FG cohort (cohorts are indicated in
different colors). The x axis and y axis indicate the first two principal components differentiating different population cohorts. We analyzed 500FG cohort to map
cytokine production QTLs in this study.
